News

Polycarbin Comes out of Stealth, Raising $2M from Ringbolt Capital and VoLo Earth Ventures to Decarbonize the Life Science and Healthcare Sector

SAN FRANCISCO–(BUSINESS WIRE)–Today, Polycarbin, Inc. announced the closing of a $2M seed round with funding from Ringbolt Capital, VoLo Earth Ventures, along with several notable angel investors to scale the only Closed-Loop solution for single-use plastics in the life science and healthcare sector.

In the midst of a pandemic that has destabilized the supply chains that provide essential plastic consumables to laboratories, Polycarbin has brought to market the only line of sustainable, circular economy laboratory products. Polycarbin is reducing the carbon footprint of innovation by turning the scientific waste of today into the laboratory products of tomorrow.

After witnessing 8 million tons of plastic waste generated during the pandemic, the industry is grappling with the consequences of the ‘single-use’ economy. Polycarbin’s mission is to reduce the carbon footprint of innovation while scaling a more sustainable and efficient supply chain to meet the needs of scientists and the low-carbon economy of the future.

As a recycler and lab product re-manufacturer, Polycarbin equips leading biotechnology, pharmaceutical, and diagnostic laboratories with a Closed-Loop platform for managing plastic disposal and green procurement, while quantifying their impact using Polycarbin’s proprietary chain of custody software.

“Polycarbin is the first real solution to address the impact that the life sciences and healthcare industry has on the global environment,” said Joe Vacca, Managing Partner of Ringbolt Capital. “We are proud to invest in a company that will forever change the way we look at the plastic waste produced by the innovation ecosystem.”

“VoLo Earth is proud to be a supporter,” Eric Riesenberg, Managing Partner, added. “I have personally dealt with the waste in the life sciences industry and, for many years, hoped for a solution like Polycarbin’s circular approach to plastic stewardship.”

Having developed the only line of circular economy lab products, Polycarbin is setting its sights on scaling production and plans to use its capital to meet the growing demand for single-use scientific plastics with a sustainable and affordable solution.

Read more here.

Recent News

09/17/2026

Rivanna Announces New CMS Procedure Code for Computer-aided Neuraxial Guidance

RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the Centers for Medicare & Medicaid Services (CMS) has established ICD-10-PCS code XEZU3HC, effective for inpatient discharges beginning October 1, 2026. The code identifies computer-aided intraprocedural navigation in the spinal canal using ultrasound imaging with continuous needle tracking via a percutaneous approach during neuraxial anesthesia.

09/17/2026

From Lab to Three Continents: Agrospheres and FMC Corporation Advance Bioinsecticide Pipeline into Global Field Trials

AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection and FMC Corporation (NYSE: FMC), a global leader in agricultural sciences, today announced a significant advancement in its ongoing collaboration. Two proprietary RNA-based biomolecule candidates from AgroSpheres’ pipeline are now entering global field trial development, marking the transition from discovery into real-world testing across three

09/15/2026

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (“Jazz” or the “Company”) today announced the successful completion of its acquisition of privately-held Actio Biosciences, Inc. (“Actio”) for $820 million upfront. Actio is now a wholly-owned subsidiary of Jazz. “ABS-1230 holds the promise of being a transformative, first-in-class therapy for individuals living with KCNT1-related epilepsy,” said Renee Gala, president and